ORCL vs SABSW · P/E 31, rev $67.36B vs P/E 0.0
Oracle Corporation (ORCL) versus SAB Biotherapeutics Inc (SABSW) — a side-by-side from cached financials, not a winner call.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Michael D. Sicilia.
SAB Biotherapeutics Inc (SABSW) common stock listed on NASDAQ.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
SABSW does not have a complete income-statement cache yet.
ORCL currently screens at market cap $527.84B and trailing P/E 31.4. SABSW currently screens at market cap $0 and trailing P/E 0.0.
Not investment advice. Open the ORCL and SABSW stock pages for the full models.
Not investment advice.